Decreased tetanic contracture of rat skeletal muscle induced by pyridostigmine

References

• Adler , M. , Maxwell , D. and Foster , R. E. 1984 . “ In vivo and in vitro pathophysiology of mammalian skeletal muscle following acute and subacute exposure to pyridostigmine. Studies on muscle contractility and cellular mechanisms ” . In Proc. IV Annu. Chemical Defense Bioscience Review 173 – 192 . Aberdeen Proving Ground, Md.
   Google Scholar
• Akaike , A. , Ikeda , S. R. , Brookes , N. , Pascuzzo , G. J. , Rickett , D. L. and Albuquerque , E. X. 1984 . The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor‐ionic channel complex . Mol. Pharmacol. , 25 : 102 – 112 .
   PubMed Web of Science ®Google Scholar
• Berry , W. K. and Davies , D. R. 1970 . The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2‐trimethylpropylmethylphosphonofluoridate . Biochem. Pharmacol. , 19 : 997 – 934 .
   Web of Science ®Google Scholar
• Birtley , R. D. N. , Roberts , J. B. , Thomas , B. H. and Wilson , A. 1966 . Excretion and metabolism of 14C‐pyridostigmine in the rat . Br. J. Pharmacol. , 26 : 393 – 402 .
   PubMed Web of Science ®Google Scholar
• Dettbarn , W.‐D. 1984 . Pesticide induced muscle necrosis: Mechanisms and prevention . Fundam. Appl. Toxicol. , 4 : S18 – S26 .
   PubMedGoogle Scholar
• Dirnhuber , P. , French , M. C. , Green , D. M. , Leadbeater , L. and Stratton , J. A. 1979 . The protection of primates against soman poisoning by pretreatment with pyridostigmine . J. Pharm. Pharmacol. , 31 : 295 – 299 .
   PubMed Web of Science ®Google Scholar
• Ellman , G. L. , Courtney , K. D. , Andres , V. and Featherstone , R. M. 1961 . A new and rapid colorimetric determination of acetylcholinesterase activity . Biochem. Pharmacol. , 7 : 88 – 95 .
   PubMed Web of Science ®Google Scholar
• Fenichel , G. M. , Kibler , W. B. , Olson , W. H. and Dettbarn , W. D. 1972 . Chronic inhibition of cholinesterase as a cause of myopathy . Neurol , 22 : 1026 – 1033 .
   PubMed Web of Science ®Google Scholar
• Gall , D. 1981 . The use of therapeutic mixtures in the treatment of cholinesterase inhibition . Fundam. Appl. Toxicol. , 1 : 214 – 216 .
   PubMedGoogle Scholar
• Gillies , J. D. and Allen , J. 1977 . Effects of neostigmine and pyridostigmine at the neuromuscular junction . Clin. Exp. Neurol. , 14 : 271 – 279 .
   PubMedGoogle Scholar
• Harris , L. and Stitcher , D. 1984 . Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine . Naunyn‐Schmiedebergs Arch. Pharmakol. , 327 : 64 – 69 .
   Google Scholar
• Hudson , C. S. and Foster , R. E. 1984 . “ Ultrastructural pathology in mammalian skeletal muscle following acute and subacute exposure to pyridostigmine. Studies of dose‐response and recovery ” . In Proc. IV Annu. Chemical Defense Bioscience Review 131 – 171 . Aberdeen Proving Ground, Md.
   Google Scholar
• Pascuzzo , G. J. , Akaike , A. , Maleque , M. A. , Shaw , K‐P. , Aronstam , R. S. , Rickett , D. L. and Albuquerque , E. X. 1984 . The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor‐ionic channel complex . Mol. Pharmacol. , 25 : 92 – 101 .
   PubMed Web of Science ®Google Scholar
• Wecker , L. and Dettbarn , W. D. 1976 . Paraoxon‐induced myopathy: Muscle specificity and acetylcholine involvelment . Exp. Neurol. , 51 : 281 – 291 .
   PubMed Web of Science ®Google Scholar
• Wecker , L. , Laskowski , M. B. and Dettbarn , W‐D. 1978 . Neuromuscular dysfunciton induced by acetylcholinesterase inhibition . Fed. Proc. , 37 : 2818 – 2822 .
   PubMedGoogle Scholar